| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 153.81B | 157.89B | 155.63B | 134.43B | 159.46B | 142.20B |
| Gross Profit | 44.82B | 45.74B | 44.16B | 37.04B | 45.48B | 40.09B |
| EBITDA | 25.06B | 26.65B | 25.60B | 19.94B | 27.82B | 23.79B |
| Net Income | 12.94B | 13.58B | 13.52B | 8.34B | 14.79B | 12.57B |
Balance Sheet | ||||||
| Total Assets | 210.26B | 226.72B | 210.87B | 208.28B | 185.63B | 172.51B |
| Cash, Cash Equivalents and Short-Term Investments | 35.35B | 42.84B | 35.33B | 28.30B | 28.57B | 34.53B |
| Total Debt | 34.32B | 34.60B | 35.80B | 37.53B | 18.63B | 17.89B |
| Total Liabilities | 73.28B | 73.18B | 74.34B | 79.18B | 65.89B | 62.94B |
| Stockholders Equity | 136.98B | 153.54B | 136.52B | 129.10B | 119.73B | 109.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.23B | 13.47B | -12.26B | -7.00M | 4.47B |
| Operating Cash Flow | 0.00 | 14.83B | 19.17B | 7.60B | 11.05B | 12.35B |
| Investing Cash Flow | 0.00 | -1.19B | -6.06B | -20.23B | -12.79B | -8.54B |
| Financing Cash Flow | 0.00 | -7.06B | -6.18B | 13.05B | -5.74B | -6.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.83B | 12.04 | ― | 3.95% | 2.75% | 25.75% | |
74 Outperform | ¥650.02B | 35.70 | 5.25% | 2.13% | -7.11% | 68.57% | |
72 Outperform | ¥451.00B | 32.18 | ― | 2.50% | 1.45% | 0.37% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥373.73B | 27.40 | ― | 1.65% | 5.02% | 19.84% | |
56 Neutral | ¥809.80B | -12.83 | 1.88% | 6.16% | 1.98% | -48.28% | |
55 Neutral | ¥755.67B | 456.64 | 5.94% | 0.56% | 7.03% | -53.53% |